Association between tumor burden and response to immunotherapy in patients with metastatic renal cell carcinoma.

被引：0
|
作者：
Yasin, Hesham Abdallah
Chen, Yu-Wei
Tucker, Matthew D.
Beckermann, Katy
Schaffer, Kerry
Davis, Nancy B.
McAlister, Renee
Wallace, Deborah
Kaiser, Elizabeth
Rini, Brian I.
机构：
[1] Vanderbilt Ingram Canc Ctr, Nashville, TN USA
[2] Vanderbilt Univ, Med Ctr, Nashville, TN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4541
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Comorbidity burden and effectiveness of immunotherapy in patients with metastatic renal cell carcinoma.
    Yekeduz, Emre
    Zarba, Martin
    Saad, Eddy
    Wells, Connor
    Machaalani, Marc
    Chehade, Razane El Hajj
    Eid, Marc
    Labaki, Chris
    Nawfal, Rashad
    Saliby, Renee Maria
    Semaan, Karl
    Steiner, Clara
    Heng, Daniel Yick Chin
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (5_SUPPL)
  • [2] Hypercoagulability could be a prognostic factor for response to immunotherapy in patients with metastatic renal cell carcinoma.
    Tsimafeyeu, Ilya
    Madzhuga, Albina
    Demidov, Lev
    CANCER RESEARCH, 2009, 69
  • [3] Relationship of tumor mutational burden (TMB) to immunotherapy response in metastatic renal cell carcinoma (mRCC).
    Maia, Manuel C.
    Almeida, Lorena
    Bergerot, Paulo Gustavo
    Dizman, Nazli
    Pal, Sumanta K.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [4] Association of the neutrophil to eosinophil ratio with response to immunotherapy-based combinations in metastatic renal cell carcinoma.
    Tucker, Matthew D.
    Beckermann, Katy
    Ancell, Kristin Kathleen
    Schaffer, Kerry
    McAlister, Renee
    Wallace, Deborah
    Kaiser, Elizabeth
    Davis, Nancy B.
    Rathmell, Kimryn W.
    Rini, Brian I.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [5] Association between primary tumor protein expression and response to sunitinib in patients with metastatic renal cell carcinoma
    Ornstein, Moshe Chaim
    Knezevic, Vlado
    Rini, Brian I.
    Vaishampayan, Ulka N.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [6] Association of resistance to antiangiogenic therapy with an immunosuppressive tumor microenvironment in metastatic renal cell carcinoma.
    Liu, Xiande
    Hoang, Anh
    Zhou, Lijun
    Kalra, Sarathi
    Yetil, Alper
    Sun, Mianen
    Ding, Zhiyong
    Tamboli, Pheroze
    Rao, Priya
    Karam, Jose A.
    Wood, Christopher G.
    Matin, Surena F.
    Zurita, Amado J.
    Bex, Axel
    Griffioen, Arjan W.
    Gao, Jianjun
    Sharma, Padmanee
    Tannir, Nizar M.
    Sircar, Kanishka
    Jonasch, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [7] Detection of circulating tumor DNA in patients with metastatic clear cell renal cell carcinoma.
    Nappi, Lucia
    Bacon, Jack
    Annala, Matti
    Soleimani, Maryam
    Lavoie, Jean-Michel
    Chi, Kim N.
    Wyatt, Alexander William
    Kollmannsberger, Christian K.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [8] Association between diabetes mellitus and the survival of sunitinib-treated patients with metastatic renal cell carcinoma.
    Suyama, Takahito
    Fujimoto, Ayumi
    Kanesaka, Manato
    Hou, Kyokushin
    Araki, Kazuhiro
    Masuda, Hiroshi
    Kojima, Satoko
    Sazuka, Tomokazu
    Nakamura, Kazuyoshi
    Nihei, Naoki
    Ichikawa, Tomohiko
    Naya, Yukio
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [9] Immunotherapy in metastatic renal cell carcinoma. With special regard to treatment of the elderly
    Heinzer, H
    Huland, E
    Huland, H
    UROLOGE A, 2003, 42 (11): : 1450 - 1452
  • [10] Treatment of metastatic renal cell carcinoma. Immunotherapy versus surgical removal
    Heinzer, H
    Huland, E
    Huland, H
    UROLOGE A, 2000, 39 (04): : 356 - 361
12345